Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 4/20 | 0.54 |
| ▸ | CA2 | P00918 | 4/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA3 | P07451 | 1/20 | 0.54 |
| ▸ | CA4 | P22748 | 1/20 | 0.54 |
| ▸ | CA6 | P23280 | 1/20 | 0.54 |
| ▸ | CA5A | P35218 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | MMP1 | P03956 | 1/20 | 0.54 |
| ▸ | MMP2 | P08253 | 1/20 | 0.54 |
| ▸ | MMP9 | P14780 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| P-Nitrophenol SCHEMBL7065303 | 1.00 | CES1 (0.56) | CES1ALDH1A1ACHEHSD17B10CA1 | |
| P-Nitrophenol SCHEMBL30132967 | 0.97 | CES1 (0.54) | CES1ALDH1A1ACHEHSD17B10CA1 | |
| P-Nitrophenol SCHEMBL29806213 | 0.97 | CES1 (0.58) | CES1ALDH1A1ACHEHSD17B10CA1 | |
| P-Nitrophenol SCHEMBL1839 | 0.97 | CES1 (0.58) | CES1ALDH1A1ACHEHSD17B10CA1 | |
| P-Nitrophenol SCHEMBL11048842 | 0.97 | CES1 (0.58) | CES1ALDH1A1ACHEHSD17B10CA1 | |
| P-Nitrophenol SCHEMBL23273098 | 0.95 | CES1 (0.56) | CES1ALDH1A1ACHEHSD17B10CA1 | |
| P-Nitrophenol SCHEMBL10883405 | 0.95 | CES1 (0.56) | CES1ALDH1A1ACHEHSD17B10CA1 | |
| P-Nitrophenol SCHEMBL7937305 | 0.95 | CES1 (0.56) | CES1ALDH1A1ACHEHSD17B10CA1 | |
| P-Nitrophenol SCHEMBL2057324 | 0.95 | CES1 (0.56) | CES1ALDH1A1ACHEHSD17B10CA1 | |
| P-Nitrophenol SCHEMBL21493265 | 0.95 | CES1 (0.56) | CES1ALDH1A1ACHEHSD17B10CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12325646-B2 | Fertigation water treatment | UNIVERSITY OF GUELPH (CA) | 2025-06-10 | — | — | US | disclosed |
| US-12304158-B2 | Aligned fibres and a method of making the same | THE UNIVERSITY OF SYDNEY (AU) | 2025-05-20 | — | — | US | disclosed |
| CN-113906055-B | Crosslinked polymers of functionalized hyaluronic acid and their use in the treatment of inflammatory states | 卓英医疗有限责任公司 | 2023-09-26 | — | — | CN | disclosed |
| US-20230138566-A1 | ALIGNED FIBRES AND A METHOD OF MAKING THE SAME | THE UNIVERSITY OF SYDNEY (AU) | 2023-05-04 | — | — | US | disclosed |
| US-20230085555-A1 | A NON-INVASIVE CONTINUOUS BLOOD GLUCOSE MONITOR | Opuz Pty Ltd (AU) | 2023-03-16 | — | — | US | disclosed |
| EP-4127259-A1 | ALIGNED FIBRES AND A METHOD OF MAKING THE SAME | The University of Sydney (AU) | 2023-02-08 | — | — | EP | disclosed |
| EP-4096513-A1 | A NON-INVASIVE CONTINUOUS BLOOD GLUCOSE MONITOR | Opuz Pty Ltd (AU) | 2022-12-07 | — | — | EP | disclosed |
| US-20220234916-A1 | WATER TREATMENT | UNIVERSITY OF GUELPH (CA) | 2022-07-28 | — | — | US | disclosed |
| US-20220213233-A1 | CROSSLINKED POLYMER OF FUNCTIONALIZED HYALURONIC ACID AND ITS USE IN THE TREATMENT OF INFLAMMATORY STATES | JOINTHERAPEUTICS S.R.L. (IT) | 2022-07-07 | — | — | US | disclosed |
| US-20220142156-A1 | FRUIT BLOSSOM END ROT-PREVENTING AGENT COMPRISING NITROPHENOL COMPOUND OR SALT THEREOF | OAT AGRIO CO., LTD. (JP) | 2022-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220142156-A1 | FRUIT BLOSSOM END ROT-PREVENTING AGENT COMPRISING NITROPHENOL COMPOUND OR SALT THEREOF | PNN, PRUNE1, GET3 | CES1 4655/4885ALDH1A1 4843/4885ACHE 92/4885 |
| US-20220213233-A1 | CROSSLINKED POLYMER OF FUNCTIONALIZED HYALURONIC ACID AND ITS USE IN THE TREATMENT OF INFLAMMATORY STATES | LGALS1, LGALS2, LGALS3 | CES1 3689/4885ALDH1A1 1482/4885ACHE 2082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.